Jun Oyanagi Last updated: Nov 21, 2019 at 22:38
Published Papers
Matsumoto Y, Sawa K, Fukui M, Oyanagi J, Izumi M, Ogawa K, Suzumura T, Watanabe T, Kaneda H, Mitsuoka S, Asai K, Kimura T, Yamamoto N, Koh Y, Kawaguchi T
Cancer Science 110(10) 3244-3254 Oct 2019 [Refereed]
Oyanagi J, Koh Y, Sato K, Mori K, Teraoka S, Akamatsu H, Kanai K, Hayata A, Tokudome N, Akamatsu K, Nakanishi M, Ueda H, Yamamoto N
Lung Cancer 132 107-113 Jun 2019 [Refereed]
Sakahara M, Okamoto T, Oyanagi J, Takano H, Natsume Y, Yamanaka H, Kusama D, Fusejima M, Tanaka N, Mori S, Kawachi H, Ueno M, Sakai Y, Noda T, Nagayama S, Yao R
Cancer Science 110(4) 1293-1305 Apr 2019 [Refereed]
Miyazaki K, Oyanagi J, Hoshino D, Togo S, Kumagai H, Miyagi Y.
Scientific Reports 9(1) 292 Jan 2019 [Refereed]
Miyazaki K, Oyanagi J, Sugino A, Sato H, Yokose T, Nakayama H, Miyagi Y
Cancer science 107(12) 1909-1918 2016 [Refereed]
Yao R, Oyanagi J, Natsume Y, Kusama D, Kato Y, Nagayama S, Noda T
Oncogene 35 6109-6119 2016 [Refereed]
Oyanagi J, Kojima N, Sato H, Higashi S, Kikuchi K, Sakai K, Matsumoto K, Miyazaki K
Experimental cell research 326(2) 267-279 2014 [Refereed]
Sato H, Oyanagi J, Komiya E, Ogawa T, Higashi S, Miyazaki K
Cancer science 105(2) 168-175 2014 [Refereed]
Kamoshida G, Ogawa T, Oyanagi J, Sato H, Komiya E, Higashi S, Miyazaki K, Tsuji T
Clinical & experimental metastasis 31(3) 285-291 2014 [Refereed]
Oyanagi J, Ogawa T, Sato H, Higashi S, Miyazaki K
PLoS ONE 7(12) e53209 Dec 2012 [Refereed]
Tsubota Y, Ogawa T, Oyanagi J, Nagashima Y, Miyazaki K
International journal of cancer 127 2013-2041 2010 [Refereed]
Matsumoto Y, Sawa K , Fukui M, Oyanagi J , Yoshimoto N, Suzumura T, Watanabe T, Kaneda H, Mitsuoka S, Asai K , Kimura T , Yamamoto N, Hirata K, Koh Y, Kawaguchi T
Lung Cancer 139 80-88 2020 [Refereed]
Akamatsu H, Murakami E, Oyanagi J, Shibaki R, Kaki T, Takase E, Tanaka M, Harutani Y, Yamagata N, Okuda Y, Furuta K, Sugimoto T, Teraoka S, Hayata A, Tokudome N, Ozawa Y, Mori K, Koh Y, Yamamoto N
The Oncologist [Refereed]
Conference Activities & Talks
Predictive values of serum protein levels in advanced NSCLC patients treated with nivolumab.
Jun Oyanagi, Yasuhiro Koh, Koichi Sato, Kuninobu Kanai, Atsushi Hayata, Hiroaki Akamatsu, Nahomi Tokudome, Keiichiro Akamatsu, Masanori Nakanishi, Hiroki Ueda, Nobuyuki Yamamoto
The 59th Annual Meeting of the Japanese Lung Cancer Society Nov 2018
Exploration of serum biomarkers predicting clinical outcome and irAEs in advanced NSCLC patients treated with nivolumab
Jun Oyanagi, Yasuhiro Koh, Koichi Sato, Kuninobu Kanai, Atsushi Hayata, Hiroaki Akamatsu, Nahomi Tokudome, Keiichiro Akamatsu, Masanori Nakanishi, Hiroki Ueda, Nobuyuki Yamamoto
The 77th Annual Meeting of the Japanese Cancer Associatioin Sep 2018
Predictive values of serum protein levels in advanced non-small-cell lung cancer patients treated with nivolumab.
Jun Oyanagi, Yasuhiro Koh, Hiroaki Akamatsu, Kuninobu Kanai, Atsushi Hayata, Nahomi Tokudome, Keiichiro Akamatsu, Masanori Nakanishi, Hiroki Ueda, Nobuyuki Yamamoto
American Association for Cancer Research 109th Annual Meeting Apr 2018
Serial evaluation of multiple serum protein levels in non-small-cell lung cancer patients treated with nivolumab.
Jun Oyanagi, Yasuhiro Koh, Hiroaki Akamatsu, Kuninobu Kanai, Atsushi Hayata, Nahomi Tokudome, Keiichiro Akamatsu, Masanori Nakanishi, Hiroki Ueda, Nobuyuki Yamamoto
AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics Oct 2017
Research Grants & Projects
JSPS:
Project Year: Apr 2019 - Mar 2022 Investigator(s): Jun Oyanagi
JSPS:
Project Year: Apr 2016 - Mar 2018
